Optogenetic stimulation of cholinergic projection neurons as an alternative for deep brain stimulation for Alzheimer’s
treatment

James Mancuso; Yuanxin Chen; Zhen Zhao; Xuping Li; Zhong Xue; Stephen T. C. Wong

doi:10.1117/12.2004379

8 March 2013 Optogenetic stimulation of cholinergic projection neurons as an alternative for deep brain stimulation for Alzheimer’s treatment

James Mancuso, Yuanxin Chen, Zhen Zhao, Xuping Li, Zhong Xue, Stephen T. C. Wong

Author Affiliations +

Proceedings Volume 8565, Photonic Therapeutics and Diagnostics IX; 85655M (2013) https://doi.org/10.1117/12.2004379
Event: SPIE BiOS, 2013, San Francisco, California, United States

Abstract

Deep brain stimulation (DBS) of the cholinergic nuclei has emerged as a powerful potential treatment for neurodegenerative disease and is currently in a clinical trial for Alzheimer’s therapy. While effective in treatment for a number of conditions from depression to epilepsy, DBS remains somewhat unpredictable due to the heterogeneity of the projection neurons that are activated, including glutamatergic, GABAergic, and cholinergic neurons, leading to unacceptable side effects ranging from apathy to depression or even suicidal behavior. It would be highly advantageous to confine stimulation to specific populations of neurons, particularly in brain diseases involving complex network interactions such as Alzheimer’s. Optogenetics, now firmly established as an effective approach to render genetically-defined populations of cells sensitive to light activation including mice expressing Channelrhodopsin-2 specifically in cholinergic neurons, provides just this opportunity. Here we characterize the light activation properties and cell density of cholinergic neurons in healthy mice and mouse models of Alzheimer’s disease in order to evaluate the feasibility of using optogenetic modulation of cholinergic synaptic activity to slow or reverse neurodegeneration. This paper is one of the very first reports to suggest that, despite the anatomical depth of their cell bodies, cholinergic projection neurons provide a better target for systems level optogenetic modulation than cholinergic interneurons found in various brain regions including striatum and the cerebral cortex. Additionally, basal forebrain channelrhodopsin-expressing cholinergic neurons are shown to exhibit normal distribution at 60 days and normal light activation at 40 days, the latest timepoints observed. The data collected form the basis of ongoing computational modeling of light stimulation of entire populations of cholinergic neurons.

Citation Download Citation

James Mancuso, Yuanxin Chen, Zhen Zhao, Xuping Li, Zhong Xue, and Stephen T. C. Wong "Optogenetic stimulation of cholinergic projection neurons as an alternative for deep brain stimulation for Alzheimer’s treatment", Proc. SPIE 8565, Photonic Therapeutics and Diagnostics IX, 85655M (8 March 2013); https://doi.org/10.1117/12.2004379

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available